Skip to content
design lab self-driving nissan toyota ford duke stanford e-hmi

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

Read Next

Don Norman Design Fund

Announcing the Norman Design Fund!

UC San Diego Design Lab is excited to announce the Norman Design Fund. The Norman Design Fund provides small, rapid allocations of funds to support student activities in human-centered design (HCD). The goal of the fund is to enhance and encourage human-centered design work by UC San Diego students. Applications are open to ALL students at UC San Diego.
Olga McConnell

Olga McConnell, Project Specialist and Executive Assistant to the Director of The Design Lab

As the Executive Assistant to the Director of The Design Lab, a project manager for the Lab’s special projects and annual events, and a lifelong learner who holds a M.A. in English Linguistics and Translation, and a M.B.A. in Business Administration and Management, Olga McConnell’s zest for knowledge is palpable. She is currently on track to complete a Project Management Certification at UC San Diego Extension at the end of 2021, and she is planning on obtaining her Project Management Professional (PMP) Certification after that. “I’m kind of addicted to getting degrees,” jokes McConnell. “I even thought the other day, maybe I’ll go to law school. And then I was like, no, enough, enough.” 

For nearly five years, McConnell was Executive Assistant to Don Norman, the Founding Director Emeritus of The Design Lab. She is now the Executive Assistant to the new Director of The Design Lab, Mai Thi Nguyen. It is Nguyen’s vision of human-technology-community interactions, along with her JEDI (justice, diversity, equity and inclusion) approach that has McConnell excited about this new chapter in the Lab’s legacy, saying, “I see how great she is as an efficient leader, so I’m really looking forward to working with her, supporting her administratively, as well as taking charge of certain projects that she has in mind.”

An Introduction to Bill Fulton, The Design Lab’s Visiting Policy Designer

An Introduction to Bill Fulton, The Design Lab’s Visiting Policy Designer How might we help…

Ucsd Design Lab Mikael Walhström

Designer in Residence & Social Psychologist Mikael Wahlström Leads Projects to Explore Autonomous Ships

The Design Lab welcomed Mikael Wahlström as a Designer in Residence this past fall. Wahlström…

Design Lab Eric Hekler Public Health Technology

Eric Hekler Joins Design Lab Team

UC San Diego Design Lab is excited to welcome Eric Hekler, an Associate Professor in…

Brian LeDuc

Brian Leduc on Learning Agility & Career Changers | Design Chats


Brian LeDuc, Design Lab Designer-In-Residence, talks about his work on creating resources for career changers.

Design Chats is a video series where we sit down with design practitioners to answer questions about how they utilize human-centered design.

View our Design Chats playlist on the Design Lab YouTube Channel
Back To Top